Abdi Ghaffari MSc, PhD

Abdi Ghaffari is currently working as a research scientist at Queen's Cancer Research Institute. He is also an adjunct assistant professor at Queen's University. Prior to the university, he is also the founder and managing director of Tika Therapeutics. He is the Head of Preclinical Research at BetterLife Pharma. He received his master's degree from the University of Alberta. He completed his Doctor of Philosophy at The University of British Columbia. He specialized in burn and wound healing.